Our Mission & Strategy
How does a company that invented Aspirin® reinvent itself?
In 2023, we started redesigning Bayer around our mission: Health for all, Hunger for none. That began with an overhaul of our operating model to better align with a fast-paced, ground-up approach to innovation and commercialisation.
We believe that innovation happens in the space between what’s needed and what’s there — not on an org chart. We’re putting an end to the hierarchical model and putting more power in the hands of our people. What does that mean? We’re reimagining every process, project, and role in the company driven by three key priorities:
/// Focusing everything on the mission
/// Advancing world-leading innovation
/// Delivering a superior financial performance
Follow our progress as we embark on this exciting journey.
Building Teams Around the Customer, Not the Boss
Traditionally, teams in large organizations are focused on things like annual budget requests. We’re redesigning our teams around what customers need today and tomorrow. By the end of 2024, our Crop Science division will have 450 customer teams up and running. Early reports indicate a 20-minute increase in time spent with customers per day.
Bigger Innovation, Shorter Timelines
Team Bayer is full of ideas on how to help farmers, patients, and consumers. We want to turn these ideas into solutions, faster. Our Consumer Health division advanced the launch of a new supplement for couples wishing to conceive by more than one year.
Picking up the Pace of Progress
Instead of long planning cycles, our new model is built on rapid 90-day cycles, with a bias for action. Our Pharmaceuticals division advanced its pipeline with eight Investigational New Drug (IND) applications in 2023. We see the potential to accelerate our biggest projects by working in three-month rhythms, assessing progress and reallocating resources along the way.
A Better Bayer is on the Way
Our teams are adapting quickly to the new working model, and we will have 100% adoption of this new system of working by the end of 2024. Through this change, we’re aiming for a more productive and fulfilled workforce; world-leading, faster-to-market innovations; and superior financial performance.
Bill Anderson joins Bayer AG as CEO.
Bayer announces new operating model “Dynamic Shared Ownership” to focus on the mission, drive innovation and strengthen performance.
In a joint declaration, the Board of Management of Bayer AG and the employee representatives on the Supervisory Board agree on principles for the future of the company, particularly in its home country of Germany.
Capital Markets Day – Bayer to share a comprehensive update on company direction.
Dynamic Shared Ownership rolled out to every corner of #TeamBayer.
